News & Updates

Show Multimedia Only

Original New Drug Application Approvals by US FDA (16-30 September 2021)

04 Oct 2021

New drug applications approved by US FDA as of 16 -30 September 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2021)

04 Oct 2021

Cervical adenocarcinoma has good survival rates when caught, treated early

03 Oct 2021

Cervical adenocarcinoma has at least a 50 percent survival rate which can be further improved by early diagnosis and individualized and comprehensive treatment, a recent study has found.

Cervical adenocarcinoma has good survival rates when caught, treated early

03 Oct 2021

Pembro + chemo: ‘Practice-changing’ in advanced cervical cancer

29 Sep 2021 by

Adding pembrolizumab to chemotherapy with or without bevacizumab significantly extends overall survival (OS) by 8 months in women with recurrent, persistent or metastatic cervical cancer, according to the KEYNOTE-826 study presented at ESMO 2021.

Pembro + chemo: ‘Practice-changing’ in advanced cervical cancer

29 Sep 2021

Product Highlight - Slinda

29 Sep 2021

Drospirenone 4 mg Film-coated Tablet

Product Highlight - Slinda

29 Sep 2021

Abnormal STE myocardial function prevalent in women with HELLP syndrome history

27 Sep 2021

The rate of abnormal speckle-tracking echocardiography (STE) myocardial function is high during the first years following a pregnancy complicated by haemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome, regardless of whether there was concomitant pre-eclampsia (PE), reveals a study.

Abnormal STE myocardial function prevalent in women with HELLP syndrome history

27 Sep 2021

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Original New Drug Application Approvals by US FDA (16-30 September 2021)

Original New Drug Application Approvals by US FDA (16-30 September 2021)

Cervical adenocarcinoma has good survival rates when caught, treated early

Cervical adenocarcinoma has good survival rates when caught, treated early

Pembro + chemo: ‘Practice-changing’ in advanced cervical cancer

Pembro + chemo: ‘Practice-changing’ in advanced cervical cancer

Product Highlight - Slinda

Product Highlight - Slinda

Abnormal STE myocardial function prevalent in women with HELLP syndrome history

Abnormal STE myocardial function prevalent in women with HELLP syndrome history